{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:28:30Z","timestamp":1791268110140,"version":"4.1.0"},"reference-count":51,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100018872","name":"Labex Immuno-oncology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100018872","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Canceropole-r\u00e9gion Ile-de-France"},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Site int\u00e9gr\u00e9 de recherche int\u00e9gr\u00e9 en canc\u00e9rologie"},{"DOI":"10.13039\/100013501","name":"Institut National contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Nationale contre le Cancer","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,4,14]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>Critically ill patients display a state of immunosuppression that has been attributed in part to decreased plasma arginine concentrations. However, we and other authors have failed to demonstrate a clinical benefit of L-arginine supplementation. We hypothesize that, in these critically ill patients, these low plasma arginine levels may be secondary to the presence of granulocytic myeloid-derived suppressor cells (gMDSC), which express arginase known to convert arginine into nitric oxide (NO) and citrulline. Indeed, in a series of 28 non-surgical critically ill patients, we showed a dramatic increase in gMDSC compared to healthy subjects (P = 0\u00b70002). A significant inverse correlation was observed between arginine levels and gMDSC (P = 0\u00b701). As expected, gMDSC expressed arginase preferentially in these patients. Patients with high gMDSC levels on admission to the medical intensive care unit (MICU) presented an increased risk of death at day 7 after admission (P = 0\u00b702). In contrast, neither plasma arginine levels, monocytic MDSC levels nor neutrophil levels were associated with overall survival at day 7. No relationship was found between body mass index (BMI) or simplified acute physiology score (SAPS) score, sequential organ failure assessment (SOFA) score or gMDSC levels, eliminating a possible bias concerning the direct prognostic role of these cells. As gMDSC exert their immunosuppressive activity via multiple mechanisms [production of prostaglandin E2 (PGE2), interleukin (IL)-10, arginase, etc.], it may be more relevant to target these cells, rather than simply supplementing with L-arginine to improve immunosuppression and its clinical consequences observed in critically ill patients.<\/jats:p>","DOI":"10.1111\/cei.12567","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T22:14:58Z","timestamp":1418076898000},"page":"280-288","source":"Crossref","is-referenced-by-count":28,"title":["Granulocytic myeloid-derived suppressor cells inversely correlate with plasma arginine and overall survival in critically ill patients"],"prefix":"10.1093","volume":"180","author":[{"given":"A","family":"Gey","sequence":"first","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Service d'Immunologie Biologique, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-M","family":"Tadie","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Service de R\u00e9animation M\u00e9dicale, Universit\u00e9 Paris Descartes, Paris, France"},{"name":"CHU Rennes, Maladies Infectieuses et R\u00e9animation M\u00e9dicale F-35033, Rennes, France"},{"name":"Inserm-CIC-F-35043 Rennes, France"},{"name":"Universit\u00e9 Rennes 1, Facult\u00e9 de M\u00e9decine, Biosit F-35043, Rennes, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Caumont-Prim","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Unit\u00e9 d'\u00c9pid\u00e9miologie et de Recherche Clinique, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hauw-Berlemont","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Service de R\u00e9animation M\u00e9dicale, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cynober","sequence":"additional","affiliation":[{"name":"H\u00f4pital Cochin, Service de Biochimie, GH HUPC, Assistance Publique H\u00f4pitaux de Paris (AP-HP), Paris, France"},{"name":"Facult\u00e9 de Pharmacie, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-Y","family":"Fagon","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Service de R\u00e9animation M\u00e9dicale, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Terme","sequence":"additional","affiliation":[{"name":"INSERM U970, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L","family":"Diehl","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Service de R\u00e9animation M\u00e9dicale, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Delclaux","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"Service de Physiologie \u2013 Clinique de la Dyspn\u00e9e, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Tartour","sequence":"additional","affiliation":[{"name":"H\u00f4pital Europ\u00e9en Georges Pompidou (HEGP), Paris, France"},{"name":"INSERM U970, Universit\u00e9 Paris Descartes, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"2021122010134211900_cei12567-bib-0001","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"2021122010134211900_cei12567-bib-0002","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.coi.2010.01.021","article-title":"Myeloid-derived suppressor cell heterogeneity and subset definition","volume":"22","author":"Peranzoni","year":"2010","journal-title":"Curr Opin Immunol"},{"key":"2021122010134211900_cei12567-bib-0003","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"2021122010134211900_cei12567-bib-0004","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s10555-011-9281-4","article-title":"Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy","volume":"30","author":"Tartour","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"2021122010134211900_cei12567-bib-0005","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.4049\/jimmunol.167.8.4293","article-title":"A schistosome-expressed immunomodulatory glycoconjugate expands peritoneal Gr1(+) macrophages that suppress naive CD4(+) T cell proliferation via an IFN-gamma and nitric oxide-dependent mechanism","volume":"167","author":"Atochina","year":"2001","journal-title":"J Immunol"},{"key":"2021122010134211900_cei12567-bib-0006","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.4049\/jimmunol.176.4.2085","article-title":"CD11b+\/Gr-1+ myeloid suppressor cells cause T cell dysfunction after traumatic stress","volume":"176","author":"Makarenkova","year":"2006","journal-title":"J Immunol"},{"key":"2021122010134211900_cei12567-bib-0007","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.4049\/jimmunol.169.6.3180","article-title":"CD80+Gr-1+ myeloid cells inhibit development of antifungal Th1 immunity in mice with candidiasis","volume":"169","author":"Mencacci","year":"2002","journal-title":"J Immunol"},{"key":"2021122010134211900_cei12567-bib-0008","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.it.2010.10.002","article-title":"Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function","volume":"32","author":"Condamine","year":"2011","journal-title":"Trends Immunol"},{"key":"2021122010134211900_cei12567-bib-0009","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1600-065X.2008.00608.x","article-title":"Arginine regulation by myeloid derived suppressor cells and tolerance in cancer: mechanisms and therapeutic perspectives","volume":"222","author":"Rodriguez","year":"2008","journal-title":"Immunol Rev"},{"key":"2021122010134211900_cei12567-bib-0010","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2141.2011.08678.x","article-title":"Myeloid-derived suppressor cells \u2013 their role in haemato-oncological malignancies and other cancers and possible implications for therapy","volume":"153","author":"Tadmor","year":"2011","journal-title":"Br J Haematol"},{"key":"2021122010134211900_cei12567-bib-0011","doi-asserted-by":"crossref","first-page":"5101","DOI":"10.1158\/0008-5472.CAN-10-2670","article-title":"Myeloid-derived suppressor cell inhibition of the IFN response in tumor-bearing mice","volume":"71","author":"Mundy-Bosse","year":"2011","journal-title":"Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0012","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.4049\/jimmunol.160.12.5729","article-title":"Macrophage-derived nitric oxide regulates T cell activation via reversible disruption of the Jak3\/STAT5 signaling pathway","volume":"160","author":"Bingisser","year":"1998","journal-title":"J Immunol"},{"key":"2021122010134211900_cei12567-bib-0013","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jim.2012.04.004","article-title":"Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples","volume":"381","author":"Kotsakis","year":"2012","journal-title":"J Immunol Methods"},{"key":"2021122010134211900_cei12567-bib-0014","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1158\/0008-5472.CAN-04-4505","article-title":"Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: a mechanism of tumor evasion","volume":"65","author":"Zea","year":"2005","journal-title":"Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0015","doi-asserted-by":"crossref","first-page":"4877","DOI":"10.1158\/1078-0432.CCR-11-2939","article-title":"Molecular pathways: tumor-infiltrating myeloid cells and reactive oxygen species in regulation of tumor microenvironment","volume":"18","author":"Lu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0016","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1002\/ijc.28622","article-title":"Subpopulations of myeloid-derived suppressor cells (MDSC) impair T cell responses through independent nitric oxide-related pathways","volume":"134","author":"Raber","year":"2013","journal-title":"Int J Cancer"},{"key":"2021122010134211900_cei12567-bib-0017","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1042\/CS20080444","article-title":"Arginine, citrulline and nitric oxide metabolism in sepsis","volume":"117","author":"Kao","year":"2009","journal-title":"Clin Sci (Lond)"},{"key":"2021122010134211900_cei12567-bib-0018","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/ajcn\/73.5.908","article-title":"Amino acid kinetics in patients with sepsis","volume":"73","author":"Druml","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"2021122010134211900_cei12567-bib-0019","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ajcn\/86.5.1438","article-title":"Plasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation","volume":"86","author":"van Waardenburg","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2021122010134211900_cei12567-bib-0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/ajcn\/84.1.197","article-title":"In vivo arginine production and intravascular nitric oxide synthesis in hypotensive sepsis","volume":"84","author":"Villalpando","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"2021122010134211900_cei12567-bib-0021","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00134-013-2984-y","article-title":"Arginine administration to critically ill patients with a low nitric oxide fraction in the airways: a pilot study","volume":"39","author":"Tadie","year":"2013","journal-title":"Intensive Care Med"},{"key":"2021122010134211900_cei12567-bib-0022","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00003246-200202000-00009","article-title":"Impairment of polymorphonuclear neutrophil functions precedes nosocomial infections in critically ill patients","volume":"30","author":"Stephan","year":"2002","journal-title":"Crit Care Med"},{"key":"2021122010134211900_cei12567-bib-0023","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1158\/1078-0432.CCR-07-0409","article-title":"Vascular endothelial growth factor-trap overcomes defects in dendritic cell differentiation but does not improve antigen-specific immune responses","volume":"13","author":"Fricke","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0024","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1158\/1078-0432.CCR-08-1332","article-title":"Sunitinib mediates reversal of myeloid-derived suppressor cell accumulation in renal cell carcinoma patients","volume":"15","author":"Ko","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0025","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1158\/0008-5472.CAN-12-2606","article-title":"PD-1-expressing tumor-infiltrating T cells are a favorable prognostic biomarker in HPV-associated head and neck cancer","volume":"73","author":"Badoual","year":"2013","journal-title":"Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0026","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/CCM.0b013e3181958cba","article-title":"Increasing plasma glutamine in postoperative patients fed an arginine-rich immune-enhancing diet \u2013 a pharmacokinetic randomized controlled study","volume":"37","author":"Loi","year":"2009","journal-title":"Crit Care Med"},{"key":"2021122010134211900_cei12567-bib-0027","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/SHK.0b013e3181d67494","article-title":"Prediction of nosocomial infection acquisition in ventilated patients by nasal nitric oxide: proof-of-concept study","volume":"34","author":"Tadie","year":"2010","journal-title":"Shock"},{"key":"2021122010134211900_cei12567-bib-0028","doi-asserted-by":"crossref","first-page":"5791","DOI":"10.4049\/jimmunol.181.8.5791","article-title":"Subsets of myeloid-derived suppressor cells in tumor-bearing mice","volume":"181","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"2021122010134211900_cei12567-bib-0029","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","article-title":"Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes","volume":"69","author":"Rodriguez","year":"2009","journal-title":"Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0030","doi-asserted-by":"crossref","first-page":"721s","DOI":"10.1158\/1078-0432.CCR-06-2197","article-title":"Arginase, prostaglandins, and myeloid-derived suppressor cells in renal cell carcinoma","volume":"13","author":"Ochoa","year":"2007","journal-title":"Clin Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0031","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/0014-5793(95)00495-U","article-title":"L-arginine depletion by arginase reduces nitric oxide production in endotoxic shock: an electron paramagnetic resonance study","volume":"366","author":"Bune","year":"1995","journal-title":"FEBS Lett"},{"key":"2021122010134211900_cei12567-bib-0032","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00726-005-0235-4","article-title":"Almost all about citrulline in mammals","volume":"29","author":"Curis","year":"2005","journal-title":"Amino Acids"},{"key":"2021122010134211900_cei12567-bib-0033","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/cc12534","article-title":"Citrulline: just a biomarker or a conditionally essential amino acid and a pharmaconutrient in critically ill patients?","volume":"17","author":"Cynober","year":"2013","journal-title":"Crit Care"},{"key":"2021122010134211900_cei12567-bib-0034","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1097\/CCM.0b013e31828c26b5","article-title":"Enterocyte damage in critically ill patients is associated with shock condition and 28-day mortality","volume":"41","author":"Piton","year":"2013","journal-title":"Crit Care Med"},{"key":"2021122010134211900_cei12567-bib-0035","doi-asserted-by":"crossref","first-page":"G1061","DOI":"10.1152\/ajpgi.00289.2007","article-title":"Manipulation of citrulline availability in humans","volume":"293","author":"Rouge","year":"2007","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2021122010134211900_cei12567-bib-0036","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s13546-013-0691-x","article-title":"Potential interest of citrulline in critically ill patients","volume":"22","author":"Cynober","year":"2013","journal-title":"Reanimation"},{"key":"2021122010134211900_cei12567-bib-0037","doi-asserted-by":"crossref","first-page":"R245","DOI":"10.1186\/cc10503","article-title":"Critical illness induces alternative activation of M2 macrophages in adipose tissue","volume":"15","author":"Langouche","year":"2011","journal-title":"Crit Care"},{"key":"2021122010134211900_cei12567-bib-0038","doi-asserted-by":"crossref","first-page":"N3","DOI":"10.1097\/00003246-200004001-00002","article-title":"Cytokine signaling-regulation of the immune response in normal and critically ill states","volume":"28","author":"Oberholzer","year":"2000","journal-title":"Crit Care Med"},{"key":"2021122010134211900_cei12567-bib-0039","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1097\/00003246-200004000-00022","article-title":"Increased nuclear factor kappa B activation in critically ill patients who die","volume":"28","author":"Paterson","year":"2000","journal-title":"Crit Care Med"},{"key":"2021122010134211900_cei12567-bib-0040","doi-asserted-by":"crossref","first-page":"7463","DOI":"10.1158\/0008-5472.CAN-11-2449","article-title":"PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment","volume":"71","author":"Obermajer","year":"2011","journal-title":"Cancer Res"},{"key":"2021122010134211900_cei12567-bib-0041","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1007\/s00262-011-1029-z","article-title":"Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4(+) T cells from patients with GI malignancy","volume":"60","author":"Mundy-Bosse","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"2021122010134211900_cei12567-bib-0042","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.0900092","article-title":"Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells","volume":"182","author":"Corzo","year":"2009","journal-title":"J Immunol"},{"key":"2021122010134211900_cei12567-bib-0043","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1084\/jem.20091474","article-title":"Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function","volume":"207","author":"Sander","year":"2010","journal-title":"J Exp Med"},{"key":"2021122010134211900_cei12567-bib-0044","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2007-07-099226","article-title":"Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity","volume":"111","author":"Movahedi","year":"2008","journal-title":"Blood"},{"key":"2021122010134211900_cei12567-bib-0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1471-2172-14-8","article-title":"Revisiting the white blood cell count: immature granulocytes count as a diagnostic marker to discriminate between SIRS and sepsis \u2013 a prospective, observational study","volume":"14","author":"Nierhaus","year":"2013","journal-title":"BMC Immunol"},{"key":"2021122010134211900_cei12567-bib-0046","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00134-003-1686-2","article-title":"Is low monocyte HLA-DR expression helpful to predict outcome in severe sepsis?","volume":"29","author":"Perry","year":"2003","journal-title":"Intensive Care Med"},{"key":"2021122010134211900_cei12567-bib-0047","doi-asserted-by":"crossref","first-page":"R163","DOI":"10.1186\/cc14003","article-title":"Neutrophils with myeloid derived suppressor function deplete arginine and constrain T cell function in septic shock patients","volume":"18","author":"Darcy","year":"2014","journal-title":"Crit Care"},{"key":"2021122010134211900_cei12567-bib-0048","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1164\/rccm.201201-0037OC","article-title":"Combination biomarkers to diagnose sepsis in the critically ill patient","volume":"186","author":"Gibot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2021122010134211900_cei12567-bib-0049","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.pcl.2008.02.009","article-title":"Immunoparalysis and adverse outcomes from critical illness","volume":"55","author":"Frazier","year":"2008","journal-title":"Pediatr Clin N Am"},{"key":"2021122010134211900_cei12567-bib-0050","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1007\/s00134-008-1213-6","article-title":"Immunonutrition in critically ill patients: a systematic review and analysis of the literature","volume":"34","author":"Marik","year":"2008","journal-title":"Intensive Care Med"},{"key":"2021122010134211900_cei12567-bib-0051","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.coph.2009.06.014","article-title":"Therapeutic targeting of myeloid-derived suppressor cells","volume":"9","author":"Ugel","year":"2009","journal-title":"Curr Opin Pharmacol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12567","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/180\/2\/280\/41791672\/cei12567.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/180\/2\/280\/41791672\/cei12567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,30]],"date-time":"2023-07-30T14:36:23Z","timestamp":1690727783000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/180\/2\/280\/6422152"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":51,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2015,4,14]]},"published-print":{"date-parts":[[2015,4,14]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12567","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2015,5]]},"published":{"date-parts":[[2015,4,14]]}}}